Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas.

Coutinho-Camillo CM, Lourenço SV, Nonogaki S, Vartanian JG, Nagai MA, Kowalski LP, Soares FA.

Virchows Arch. 2013 Jul;463(1):31-9. doi: 10.1007/s00428-013-1438-9. Epub 2013 Jun 9.

PMID:
23748915
2.

Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.

Bose P, Klimowicz AC, Kornaga E, Petrillo SK, Matthews TW, Chandarana S, Magliocco AM, Brockton NT, Dort JC.

BMC Cancer. 2012 Aug 1;12:332. doi: 10.1186/1471-2407-12-332.

3.

FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.

Wen Q, Alnemah MM, Luo J, Wang W, Chu S, Chen L, Li J, Xu L, Li M, Zhou J, Fan S.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8236-43. eCollection 2015.

4.

Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.

Nagai MA, Fregnani JH, Netto MM, Brentani MM, Soares FA.

Breast Cancer Res Treat. 2007 Nov;106(1):49-56. Epub 2007 Jan 9.

PMID:
17211533
5.

Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma.

Coutinho-Camillo CM, Lourenço SV, Nishimoto IN, Kowalski LP, Soares FA.

Histopathology. 2010 Aug;57(2):304-16. doi: 10.1111/j.1365-2559.2010.03621.x.

PMID:
20716171
6.

Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.

Tripathi SC, Kaur J, Matta A, Gao X, Sun B, Chauhan SS, Thakar A, Shukla NK, Duggal R, Choudhary AR, DattaGupta S, Sharma MC, Ralhan R, Siu KW.

Mod Pathol. 2012 Jan;25(1):14-25. doi: 10.1038/modpathol.2011.145. Epub 2011 Oct 14.

7.

Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.

Klimowicz AC, Bose P, Nakoneshny SC, Dean M, Huang L, Chandarana S, Magliocco AM, Wayne Matthews T, Brockton NT, Dort JC.

Eur J Cancer. 2012 Sep;48(14):2166-74. doi: 10.1016/j.ejca.2012.04.010. Epub 2012 Aug 12.

PMID:
22892062
8.

Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma.

Monteiro LS, Diniz-Freitas M, Garcia-Caballero T, Warnakulasuriya S, Forteza J, Fraga M.

J Oral Pathol Med. 2012 Aug;41(7):559-67. doi: 10.1111/j.1600-0714.2012.01142.x. Epub 2012 Mar 14.

PMID:
22417132
9.

Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma.

Parris TZ, Aziz L, Kovács A, Hajizadeh S, Nemes S, Semaan M, Chen CY, Karlsson P, Helou K.

BMC Cancer. 2014 May 7;14:324. doi: 10.1186/1471-2407-14-324.

10.

High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.

Moura IM, Delgado ML, Silva PM, Lopes CA, do Amaral JB, Monteiro LS, Bousbaa H.

J Oral Pathol Med. 2014 Mar;43(3):225-31. doi: 10.1111/jop.12115. Epub 2013 Sep 16.

PMID:
24044615
11.

Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.

Fang KH, Kao HK, Chi LM, Liang Y, Liu SC, Hseuh C, Liao CT, Yen TC, Yu JS, Chang KP.

Laryngoscope. 2014 Sep;124(9):E354-60. doi: 10.1002/lary.24700. Epub 2014 May 27.

PMID:
24706327
12.

EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival.

Monteiro LS, Delgado ML, Ricardo S, Garcez F, do Amaral B, Pacheco JJ, Lopes C, Bousbaa H.

Biomed Res Int. 2014;2014:905680. doi: 10.1155/2014/905680. Epub 2014 May 21.

13.

Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.

Zhao P, Lu Y, Liu L.

Int J Clin Exp Pathol. 2015 May 1;8(5):5230-5. eCollection 2015.

14.

Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma.

Buim ME, Lourenço SV, Carvalho KC, Cardim R, Pereira C, Carvalho AL, Fregnani JH, Soares FA.

Oral Oncol. 2010 Mar;46(3):166-71. doi: 10.1016/j.oraloncology.2009.11.009. Epub 2010 Jan 8.

PMID:
20060356
15.

Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas.

Tu HF, Chang KW, Cheng HW, Liu CJ.

Laryngoscope. 2015 Nov;125(11):E365-70. doi: 10.1002/lary.25464. Epub 2015 Jul 7.

PMID:
26152520
16.

Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.

Yu SY, Wang YP, Chang JY, Shen WR, Chen HM, Chiang CP.

J Oral Pathol Med. 2014 May;43(5):344-9. doi: 10.1111/jop.12134. Epub 2013 Nov 18.

PMID:
24245508
17.

Caspase expression in oral squamous cell carcinoma.

Coutinho-Camillo CM, Lourenço SV, Nishimoto IN, Kowalski LP, Soares FA.

Head Neck. 2011 Aug;33(8):1191-8. doi: 10.1002/hed.21602. Epub 2010 Nov 12.

PMID:
21755562
18.

Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.

PMID:
20868995
19.

Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma.

Leung KW, Tsai CH, Hsiao M, Tseng CJ, Ger LP, Lee KH, Lu PJ.

Oncol Rep. 2009 Apr;21(4):1097-104.

PMID:
19288014
20.

HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis.

Bitu CC, Destro MF, Carrera M, da Silva SD, Graner E, Kowalski LP, Soares FA, Coletta RD.

BMC Cancer. 2012 Apr 12;12:146. doi: 10.1186/1471-2407-12-146.

Supplemental Content

Support Center